The use of PESTEL as a change management tool to inform change management of polypharmacy and adherence within SIMPATHY program
Journal Article
Geitona, M., Vontetsianos, T., Mair, A., Mc Kenzie, D., Michael, N., Kousoulakou, H., …Balasopoulou, A. (2016)
The use of PESTEL as a change management tool to inform change management of polypharmacy and adherence within SIMPATHY program. International journal of integrated care, 16(6), A52. https://doi.org/10.5334/ijic.2995
Introduction: Polypharmacy and medication adherence in the older populationwith multiple chronic conditionsare significant public health issues across all the European Union (...
Guidance to manage inappropriate polypharmacy in older people: systematic review and future developments
Journal Article
Lewek, P., MacLure, K., McIntosh, J., Alonso, A., Kardas, P., Wilson, M., …Stewart, D. (2016)
Guidance to manage inappropriate polypharmacy in older people: systematic review and future developments. Expert Opinion on Drug Safety, 16(2), 203-213. https://doi.org/10.1080/14740338.2017.1265503
Introduction: Single disease state led evidence-based guidelines do not provide sufficient coverage of issues of multimorbidities, with the cumulative impact of recommendation...
Polypharmacy management: an under recognized public health issue
Journal Article
McIntosh, J., Alonso, A., Codina, C., & Mair, A. (2016)
Polypharmacy management: an under recognized public health issue. European Journal of Public Health, 26(suppl_1), https://doi.org/10.1093/eurpub/ckw174.050
Background
Multiple chronic diseases in individuals increase the risk of inappropriate polypharmacy, an under recognised public health issue. SIMPATHY (Stimulating Innovation ...
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
Journal Article
Bousquet, J., Farrell, J., Crooks, G., Hellings, P., Bel, E. H., Bewick, M., …Mercier, J. (2016)
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5). Clinical and Translational Allergy, 6, https://doi.org/10.1186/s13601-016-0116-9
Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focuses on the integrated care of chronic diseases. Area 5 (Care Pathways) was ...
Prescribing to fit the needs of older people – the NHS Scotland Polypharmacy Guidance, 2nd edition
Journal Article
Wilson, M., Mair, A., Dreischulte, T., & Witham, M. (2015)
Prescribing to fit the needs of older people – the NHS Scotland Polypharmacy Guidance, 2nd edition. Journal of the Royal College of Physicians of Edinburgh, 45(2), 108-113. https://doi.org/10.4997/jrcpe.2015.204
Polypharmacy: Manage Medicines App
Digital Artefact
Mair, A. (2015)
Polypharmacy: Manage Medicines App. [App]
Integrated care pathways for airway diseases (AIRWAYS-ICPs)
Journal Article
Bousquet, J., Addis, A., Adcock, I., Agache, I., Agusti, A., Alonso, A., …Zuberbier, T. (2014)
Integrated care pathways for airway diseases (AIRWAYS-ICPs). European Respiratory Journal, 44(2), 304-323. https://doi.org/10.1183/09031936.00014614
Prescription For Excellence
Report
Scottish Government. (2013)
Prescription For Excellence. Edinburgh: Scottish Government
Policy document setting out the vision for pharmacy. A vision and action plan for the future of NHS pharmaceutical care in Scotland through integrated partnerships and innovat...